Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.58 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.50 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.45 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1678631 | 0.98 | TRPA1 (0.55) | TRPA1TRPV1SIGMAR1CSNK1EKCNH2 | |
| SCHEMBL6671960 | 0.93 | TRPA1 (0.58) | TRPA1TRPV1SIGMAR1CSNK1EKCNH2 | |
| SCHEMBL3652085 | 0.93 | SIGMAR1 (0.49) | TRPA1TRPV1SIGMAR1CSNK1EKCNH2 | |
| SCHEMBL14402447 | 0.93 | SIGMAR1 (0.49) | TRPA1TRPV1SIGMAR1CSNK1EKCNH2 | |
| SCHEMBL19682101 | 0.91 | TRPA1 (0.67) | TRPA1TRPV1SIGMAR1MAPTRXFP1 | |
| SCHEMBL26914633 | 0.89 | CSNK1E (0.55) | TRPA1TRPV1SIGMAR1CSNK1EKCNH2 | |
| SCHEMBL5806427 | 0.87 | TRPA1 (0.59) | TRPA1TRPV1SIGMAR1CSNK1EMAPT | |
| SCHEMBL1678754 | 0.87 | TRPA1 (0.59) | TRPA1TRPV1SIGMAR1CSNK1EMAPT | |
| SCHEMBL9279770 | 0.86 | CSNK1E (0.55) | TRPA1TRPV1SIGMAR1CSNK1EKCNH2 | |
| SCHEMBL5806424 | 0.86 | CSNK1E (0.55) | TRPA1TRPV1SIGMAR1CSNK1EKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7923573-B2 | Benzene compound having 2 or more substituents | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-04-12 | — | — | US | disclosed |
| US-20080255111-A1 | Tissue Factor Production Inhibitor | SANKYO COMPANY LIMITED (JP) | 2008-10-16 | — | — | US | disclosed |
| US-20080004301-A1 | Benzene Compound Having 2 or More Substituents | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2008-01-03 | — | — | US | disclosed |
| EP-1806332-A1 | BENZENE COMPOUND HAVING 2 OR MORE SUBSTITUENTS | Daiichi Sankyo Company, Limited (JP) | 2007-07-11 | — | — | EP | disclosed |
| EP-1764075-A1 | TISSUE FACTOR PRODUCTION INHIBITOR | Sankyo Company, Limited (JP) | 2007-03-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255111-A1 | Tissue Factor Production Inhibitor | PTAFR, PLAT, TFPI | TRPA1 2141/4885TRPV1 3360/4885SIGMAR1 4028/4885 |
| US-20080004301-A1 | Benzene Compound Having 2 or More Substituents | NR1H2, NR1H3, NCOR2 | TRPA1 1743/4885TRPV1 2762/4885SIGMAR1 706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.